SM88 in Patients with Prostate Cancer
Español  |  中國傳統的  |  简体中文
Call us  (855) 528-7322
Main Menu

SM88 in Patients with Prostate Cancer

Sponsor: Tyme, Inc

Enrolling in our Bronx locations. Tyme 2016b: A phase 1b/2 trial of the SM88 treatment regimen in patietns with prostate cancer.